Company: ATRA
Filing Date: 2025-07-14
Form Type: 8-K
Source: 0001193125-25-158719
Chunk: 0

Company: Atara Biotherapeutics, Inc.
Filing Date: 2025-07-14
Form: 8-K
Item: Item 2.02
Chunk 0
---
Item 2.02 Results of Operations and Financial Condition.

In connection with the press release described in Item 8.01 below, on July 14, 2025, Atara Biotherapeutics, Inc. (the “ Company”) announced the Company’s cash, cash equivalents and short-term investments as of June 30, 2025. The preliminary estimate is based on currently available information and does not present all necessary information for a complete understanding of the Company’s financial condition as of June 30, 2025 or the Company’s results of operations for the second quarter ended June 30, 2025.